Test Portfolio Performance Against Strategic Venture DNA
Compare the ranked portfolio against the corporate parent's core strategic mandates, investment hurdles, and risk appetite parameters. Stress-test top-tier ventures against strategic alignment criteria to verify they genuinely fit the long-term corporate thesis.
Completing this action verifies that high-scoring ventures directly advance the parent company's core strategic objectives. It prevents the venture programme from backing profitable but strategically irrelevant distractions.
The founder must produce a strategic alignment map overlaying portfolio rankings onto corporate venture DNA criteria. This document must explicitly flag any high-performing ventures that diverge from core business strategy or compliance guardrails.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
How specifically does the highest-ranked venture align with the parent entity's five-year strategic growth pillars?
- 2
What compromises in corporate core capabilities are required if we choose to scale the top-ranked initiative?
- 3
Where does the venture DNA explicit risk tolerance conflict with the actual risk profile of these top ventures?
- 4
Why should the corporate entity continue funding a venture that meets revenue targets but fails strategic alignment tests?
- 5
How well do the underlying business models of these initiatives survive changes in the parent company's market position?